What’s new in the stem cell, cell therapy, and regenerative medicine world as well as biomedical science more generally including cancer? There’s quite a bit of news as reflected in media pieces and new pubs. Today’s post is focused on pubs that just came out. For last week’s recommended reads see here. Oct4-Sox2 Nucleosome Binding […]
OCT4-SOX DNA dance, PRC2, a noisy competition & more cell weekly reads Read More »
Katie Thomas at the New York Times reports that BARDA has dropped considering funding applications for stem cells for COVID-19. The move is part of a larger shift in funding priorities away from lung treatments and toward vaccine development. The decision has puzzled and even angered some stem cell firms and researchers. BARDA stands for
BARDA drops funding of research into stem cells for COVID-19 Read More »
One of the most common questions that patients have asked me over the last decade is, “how much does stem cell therapy cost?” They actually seem most often to want to know more specifically how much the treatments should cost. To try to authoritatively answer this we need data from the present and past along
How much does stem cell therapy cost in 2022? Read More »
A variety of states have stepped up to address unproven stem cell clinics within their borders and the latest is Vermont. According to the VTDigger and writer Anne Wallace Allen, the Vermont Medical Society is planning a number of steps to address this situation. For example, at their encouragement a Vermont lawmaker will introduce legislation
Vermont zeroes in on unproven stem cell clinics Read More »
As of October 1, Google was supposed to have banned ads for unproven stem cell clinics and products. This was according to their own new policy. How’s that going? How’s this new Google approach to unproven stem cell marketing working out in the real wild world of the web? To test it, I did over
My B grade to Google on early test of its stem cell clinic ad ban Read More »
The Washington Post broke the story this morning that Google has a new biomedical ad policy that may really shake things up for stem cell clinics. The search giant announced the new policy on its blog that will restrict advertisements for unproven stem cell clinics, cellular and gene therapies. This is great news. Google new
Google to block unproven stem cell clinic & gene therapy ads Read More »
We’re seeing more muddy waters in the stem cell universe. A chiropractic stem cell and alternative medicine clinic has popped up calling itself, of all things, CIRM. On another front, an already controversial docuseries set to air tomorrow combines interviews with prominent academic stem cell scientists and unproven stem cell clinic folks, muddying the waters.
Muddy waters: stem cell clinic calls itself CIRM & docuseries sparks controversy Read More »
There’s a lot of questionable “stem cell” injections these days involving purported amniotic stem cell or other perinatal (birth-related) material. Regulators are taking note including the FTC, which took some unprecedented action last year on this front. Now the FTC has announced that more than half a million $USD have been returned to consumers who
There is real hope for treating spinal cord injury with stem cell-based therapies in the future. However, unfortunately regulators in Japan have taken a major misstep in approving a not-ready-for-primetime mesenchymal stem cell (MSC)-based approach to spinal cord injury. Their decision is dangerous and unwise. In a Nature piece (linked to above) by David Cyranoski
Japan’s dangerous gamble approving unproven stem cells for spinal cord injury Read More »
There are gray areas within the larger stem cell sphere or as I called it in a recent paper “the stem cell ecosystem“, but chiropractors doing stem cell transplants is not one of them. This is unethical and risky on many levels, but the number of chiropractors selling stem cells is increasing rapidly nonetheless. Chiropractors
Chiropractors and their state boards should stop risky stem cell injections Read More »